ASA brand laser therapy: the key to effectively treat lateral epicondylitis

12 September 2023 - Research -
Share

Tired of enduring the nagging pain of lateral epicondylitis, commonly known as tennis elbow?

Get ready for some exciting news! A study published in the European Chemical Bulletin (Eur. Chem. Bull. 2023, 12 (S3), 593 – 604) revealed the remarkable potential of laser therapy in relieving the discomfort associated with this condition. In this article, we will review the results of this research and shed light on the results obtained using the high-intensity laser therapy (HILT) and the high-power, “low-intensity” laser therapy (LILT) devices manufactured by ASA.

Study overview

The research, conducted by Hamed et al. in Cairo, Egypt, presents the results of a randomised controlled trial aiming to evaluate the efficacy of two different laser therapies in the treatment of lateral epicondylitis. The study involved patients with lateral epicondylitis diagnosed more than a month previously who received a combination of stretching exercises and HILT or LILT therapy.

Study Design and Groups

40 patients were divided into two homogeneous groups:

  • The 20 patients in Group A received HILT treatments with the HIRO TT device in combination with stretching exercises (HILT + Ex). Each session had three phases: fast scan, trigger point and slow scan, targeting specific points.
  • The remaining 20 patients in Group B received LILT treatments with the Mphi 5 device in combination with stretching exercises (LILT + Ex). Six points in the lateral epicondyle area were treated during each laser session.

The protocol consisted of three sessions per week for four weeks, for a total of 12 sessions for each patient.

Laser therapy: scientifically proven efficacy

The effectiveness of the treatments was evaluated using the following methods:

  • Pain intensity, measured using the Visual Analogue Scale (VAS).
  • Grip strength, assessed with a digital hand dynamometer.
  • Functional disability, assessed by using the DASH (Disabilities of the Arm, Shoulder, and Hand) questionnaire, where a high score indicates greater disability.

The study, evaluating each test both pre and post treatment for each group, underlines the effectiveness of both ASA brand therapies: both Hilterapia® and MLS® Laser Therapy reduce pain intensity and functional disability, increasing grip strength in patients with lateral epicondylitis. By directly comparing both systems covered by the Study, it should be highlighted that the treatments with HIRO TT offer an even faster relief and show results in fewer sessions than those with the Mphi 5 device.

Hilterapia® and MLS® Laser Therapy therefore offer a faster and more significant possibility of healing for those suffering from lateral epicondylitis and seeking relief from this debilitating condition.

You might also be interested in ...

See all articles

Effect of NIR Laser Therapy by MLS‐MiS Source on Fibroblast Activation by Inflammatory Cytokines in Relation to Wound Healing
blog - 12/04/2021
The ASA device have an important anti-inflammatory effect, but it is also effective in controlling fibroblast activation induced by IL‐1β and TNF‐α, probably responsible for a detrimental effect on...
Research - Lasers in Medical Science Journal
Research
U. Dundar, U. Turkmen, H. Toktas, A. M. Ulasli, O. Solak Lasers in medical science 30.3, 2015 Lateral epicondylitis (LE) is a common disorder that causes pain on the outside of the elbow, as well as...
European Chemical Bulletin
Research
S.M. Hamed, Y.F. Ahmed, K. Ghuiba, K.S. Ibrahim, E.J. Hassan European Chemical Bulletin, 12 (S3), 593 – 604, DOI: 10.31838/ecb/2023.12.s3.068, 2023 In contrast to LILT, the treatment impact of HILT...
ASA tema @ ArabHealth 2024
News - 15/02/2024
In order to provide maximum visibility and the best dissemination of the strengths of its Therapeutic Solutions, the company preceded its attendance at the fair (Dubai, 29th January – 1st February)...
Neuropatic pain
Blog - 05/02/2024
The clinical research* conducted by Dr. Yosifova, as published in the Journal of IMAB, highlights the promising role of ASA's M6 robotic laser in mitigating neuropathic pain associated with diabetic...
ASA @ Medica 2023
News - 02/12/2023
The occasion to best celebrate ASA’s 40th birthday could only be Medica. The fair in Düsseldorf in fact represented the occasion to share this important milestone with both loyal and new customers.